An implanted cardiac defibrillator (ICD) is a unique indwelling device for the treatment of cardiac dysrhythmia and the prevention of sudden cardiac death. On February 4, 1980, the first ICD was implanted into a human subject. Thousands of Americans have been saved as a result of this device. Near the end of life, an active ICD may no longer be consistent with a patient’s needs and/or current health status. The very benefit of the device becomes the risk. Research has shown a deficit in recipient understanding of the role and function of the ICD. Likewise, there is a deficit in physician-led discussions and education of ICD deactivation in end-of-life care.
KirkpatrickJNGottliebMSehgalPPatelRVerdinoRJ. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol. 2012;109:91-94.
2.
RussoJE. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Am J Nurs. 2011;111:26-35.
3.
SinghBSinghJ. ICD’s near end of life: risk versus benefit—a review. Am J Hosp Palliat Care. 2012;29:421-430.
4.
ConeliusJ. A literature review: advance directives and patients with implantable cardioverter defibrillators. J Am Acad Nurse Pract. 2010;22:250-255.
5.
BeyerbachDMRottmanJNSulemanAPearlmanJDTalaveraFOlshanskyB. Pacemakers and implantable cardioverter-defibrillators. Medscape. 2012. Available at: http://emedicine.medscape.com/article/162245-overview. Accessed December 28, 2012
6.
ClarkAMJaarsmaTStrachanP. Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardiol. 2011;8:694-705.
7.
GoldsteinNMehtaDSiddiquiS. “That’s like an act of suicide” patients’ attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2008;23:7-12.
8.
HammillSCKremersMSStevensonLW. Review of the registry’s fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010;7:1340-1345.
9.
HarringtonMDLuebkeDLLewisWRAulisioMPJohnsonNJ. Implantable cardioverter defibrillator (ICD) at end of life #112. J Palliat Med. 2005;8:1056-1057.
10.
WithellB. Patient consent and implantable cardioverter defibrillators: some palliative care implications. Int J Palliat Nurs. 2006;12:470-475.
11.
FrommeEKLugliani StewartTJeppesenMTolleSW. Adverse experiences with implantable defibrillators in Oregon hospices. Am J Hosp Palliat Care. 2011;28:304-309.
12.
StewartGCWeintraubJRPratibhuPP. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010;16:106-113.
13.
MuellerPSHookCCHayesDL. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc. 2003;78:959-963.
14.
SheraziSDaubertJPBlockRC. Physicians’ preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc. 2008;83:1139-1141.
15.
SulmasyD. Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med. 2008;23:69-72.
16.
GoldsteinNLampertRBradleyELynnJKrumholzHM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835-838.
17.
DuruFBüchiSKlaghoferR. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life?Heart. 2001;85:375-379.
18.
SearsSFMatchettMContiJB. Effective management of ICD patient psychosocial issues and patient critical events. J Cardiovasc Electrophysiol. 2009;20:1297-1304.
19.
KobzaRErneP. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol. 2007;30:845-849.
20.
KapaSMuellerPSHayesDLAsirvathamSJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc. 2010;85:981-990.
21.
RaphaelCEKoa-WingMStainNWrightIANFrancisDPKanagaratnamP. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?Pacing Clin Electrophysiol. 2011;34:1628-1633.
22.
StrachanPCarrollSde LaatSSchwartzLArthurH. Patients’ perspectives on end-of-life issues and implantable cardioverter defibrillators. J Palliat Care. 2011;27:6-11.
23.
MatlockDDNowelsCTMasoudiFA. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34:1634-1644.
24.
PadelettiLArnarDOBoncinelliL. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010;12:1480-1489.
